Google
MIRA — MIRA PHARMACEUTICALS, INC. COMMON STOCK (Healthcare >> Drug Manufacturers - General)
MIRA FAQ
What is MIRA's ROE?
MIRA PHARMACEUTICALS, INC. COMMON STOCK reports a Return on Equity (ROE) of -104.92%.
What is MIRA's dividend yield?
MIRA PHARMACEUTICALS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is MIRA's Deepscope Quality Score?
Deepscope rates MIRA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MIRA?
Deepscope's AI Timing Score for MIRA is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MIRA belong to?
MIRA PHARMACEUTICALS, INC. COMMON STOCK is classified under the Healthcare >> Drug Manufacturers - General sector on the NASDAQ exchange.
|
USD 1.00
Price
-0.06
(-5.66%)
Day Change
|
|
|---|
MIRA, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.00 |
| PBV / Sector |
4.54 / 2.84
|
| Earning Per Share | -0.23 |
| PE / Sector |
N/A / 24.53
|
| PEG or PE/Growth / Sector |
N/A / 0.08
|
| Average 1M Daily Value |
0.14 M
GREAT
|
| Average 1W Daily Value |
0.13 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:03 |
| Symbol | MIRA |
| Name | MIRA PHARMACEUTICALS, INC. COMMON STOCK |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 42.02 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 42.44 / 241,254.65 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1200 Brickell Avenue, Miami, FL, United States, 33131
Phone: 786 432 9792
Website: https://mirapharmaceuticals.com
Description: MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
